دورية أكاديمية

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

التفاصيل البيبلوغرافية
العنوان: Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC
المؤلفون: Chu, Tianqing, Zhong, Runbo, Zhong, Hua, Zhang, Bo, Zhang, Wei, Shi, Chunlei, Qian, Jialin, Zhang, Yanwei, Chang, Qing, Zhang, Xueyan, Dong, Yu, Teng, Jiajun, Gao, Zhiqiang, Qiang, Huiping, Nie, Wei, Zhao, Yiming, Han, Yuchen, Chen, Ya, Han, Baohui
المصدر: In Journal of Thoracic Oncology April 2021 16(4):643-652
قاعدة البيانات: ScienceDirect
الوصف
تدمد:15560864
DOI:10.1016/j.jtho.2020.11.026